Effects of Thoracolumbar Fascia Myofascial Release in Chronic Low Back Pain
TLF-MFR-LBP
Effects of Myofascial Release Targeting the Thoracolumbar Fascia on Fascial Morphology, Functional Outcomes, and Pain Self-Efficacy in Adults With Chronic Non-Specific Low Back Pain: A Randomized Controlled Trial
1 other identifier
interventional
65
1 country
1
Brief Summary
The thoracolumbar fascia (TLF) is thickened and stiffer in individuals with chronic non-specific low back pain (CNSLBP) and may contribute to pain persistence. Myofascial release (MFR) has been shown to reduce TLF stiffness acutely; however, its longer-term effects on fascial morphology and pain self-efficacy remain unclear. This randomized controlled trial will investigate the effects of a standardized 6-week MFR program targeting the thoracolumbar fascia compared with sham MFR in adults with CNSLBP. A total of 65 participants aged 18-60 years with CNSLBP will be randomized in a 1:1 ratio to either standardized MFR or sham MFR. The intervention will consist of 18 treatment sessions delivered over 6 weeks. Primary outcomes include thoracolumbar fascia thickness measured by B-mode ultrasound, thoracolumbar fascia stiffness measured by shear-wave elastography, and pain self-efficacy measured using the Pain Self-Efficacy Questionnaire (PSEQ). Secondary outcomes include pain intensity, functional disability, lumbar flexion range of motion, and patient global impression of change. Outcomes will be assessed at baseline and after completion of the 6-week intervention period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2026
CompletedStudy Start
First participant enrolled
June 20, 2026
CompletedFirst Posted
Study publicly available on registry
June 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
CompletedJune 26, 2026
June 1, 2026
1 month
June 18, 2026
June 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Thoracolumbar Fascia Thickness
Change in thoracolumbar fascia thickness measured using B-mode ultrasound imaging
Baseline and 6 weeks
Thoracolumbar Fascia Stiffness
Change in thoracolumbar fascia stiffness measured using shear-wave Sonoelastography.
Baseline and 6 weeks
Pain Self-Efficacy (PSEQ)
Change in pain self-efficacy measured using the Pain Self-Efficacy Questionnaire (PSEQ), a 10-item questionnaire assessing confidence in performing activities despite pain. Total scores range from 0 to 60, with higher scores indicating better pain self-efficacy (greater confidence in functioning despite pain).
Baseline and 6 weeks
Secondary Outcomes (4)
Pain Intensity (Numeric Rating Scale)
Baseline and 6 weeks
Functional Disability (Oswestry Disability Index)
Baseline and 6 weeks
Lumbar Flexion Range of Motion
Baseline and 6 weeks
Patient Global Impression of Change (PGIC)
6 weeks
Study Arms (2)
Myofascial Release Group
EXPERIMENTALParticipants in this group will receive standardized myofascial release targeting the thoracolumbar fascia. The intervention will consist of 18 sessions over 6 weeks (3 sessions per week), each lasting approximately 40 minutes. The technique involves sustained low-load manual pressure using a crossed-hands approach applied to bilateral L2-L3 and L4-L5 regions of the thoracolumbar fascia. Treatment will be delivered by a trained physiotherapist following a standardized protocol. No additional physiotherapy interventions will be provided during the study period
Sham Myofascial Release Group
SHAM COMPARATORParticipants in this group will receive sham myofascial release targeting the same anatomical regions as the experimental group. Light manual contact (\<50 g force) will be applied without therapeutic pressure or fascial engagement. The session duration and frequency will be identical to the experimental group (18 sessions over 6 weeks, 3 sessions per week, approximately 40 minutes per session). Participants will receive identical positioning and therapist contact time to control for placebo and attention effects.
Interventions
Standardized myofascial release targeting the thoracolumbar fascia will be administered over 18 sessions across 6 weeks (3 sessions per week). Each session will last approximately 40 minutes and will involve sustained low-load manual pressure using a crossed-hands technique applied bilaterally at L2-L3 and L4-L5 regions. The intervention aims to reduce fascial stiffness and improve tissue mobility. Treatment will be delivered by a trained physiotherapist following a standardized protocol. No additional physiotherapy interventions will be provided during the study period
Sham myofascial release will be applied over the same anatomical regions as the experimental group using light manual contact (\<50 g force) without therapeutic pressure or fascial engagement. Sessions will be matched in duration (approximately 40 minutes), frequency (3 sessions per week), and total duration (6 weeks, 18 sessions). The aim is to control for placebo effects, therapist attention, and patient expectation
Eligibility Criteria
You may qualify if:
- Adults aged 18-60 years
- Non-specific low back pain duration \> 12 weeks
- Average pain intensity NRS ≥ 3 over the past week
- Able to provide written informed consent
- Able to attend 18 supervised sessions over 6 weeks (3 sessions/week)
You may not qualify if:
- Specific spinal pathology (fracture, disc herniation with neurological deficit, spinal stenosis, inflammatory arthropathy, malignancy)
- Previous lumbar surgery
- Current pregnancy
- Severe psychiatric disorder or active psychosis
- Manual therapy or physiotherapy for LBP within the previous 3 months
- Systemic connective tissue disorder (e.g., Ehlers-Danlos syndrome, Marfan syndrome)
- Contraindication to ultrasound imaging or manual therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Affiliated Teaching Hospitals of University of Health Sciences Lahore
Lahore, Punjab Province, Pakistan
Related Publications (1)
Devantery K, Morin M, Grimard J, Gaudreault N. Effects of a Myofascial Technique on the Stiffness and Thickness of the Thoracolumbar Fascia and Lumbar Erector Spinae Muscles in Adults with Chronic Low Back Pain: A Randomized before-and-after Experimental Study. Bioengineering (Basel). 2023 Mar 6;10(3):332. doi: 10.3390/bioengineering10030332.
PMID: 36978723BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors will be blinded to group allocation. Participants and care providers will not be blinded due to the nature of manual therapy intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 18, 2026
First Posted
June 24, 2026
Study Start
June 20, 2026
Primary Completion
August 1, 2026
Study Completion
August 1, 2026
Last Updated
June 26, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared. Data will be retained by the investigators and institution in accordance with ethical and confidentiality requirements